Beyer, Susanne
Müller, Lena
Mitter, Sophie
Keilmann, Lucia
Meister, Sarah
Buschmann, Christina
Kraus, Fabian
Topalov, Nicole E.
Czogalla, Bastian
Trillsch, Fabian
Burges, Alexander
Mahner, Sven
Schmoeckel, Elisa
Löb, Sanja
Corradini, Stefanie
Kessler, Mirjana
Jeschke, Udo
Kolben, Thomas
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 25 July 2022
Accepted: 5 August 2022
First Online: 7 September 2022
Declarations
:
: F. Trillsch declares Research support, advisory board, honoraria and travel expenses from Astra-Zeneca, Clovis, Eisai, Medac, MSD, PharmaMar, Roche, Tesaro/GSK. A. Burges declares advisory board and honoraria from AstraZeneca, Roche, Tesaro. S. Mahner has received Research support, advisory board, honoraria and travel expenses from AstraZeneca, Clovis, Eisai, GlaxoSmithKline, Medac, MSD, Novartis, Olympus, PharmaMar, Roche, Sensor Kinesis, Teva, Tesaro. T. Kolben has a relative employed at Roche and holds stock of Roche. All other authors declare that they have no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the ethics committee of the Ludwig-Maximilians-University Munich (reference number: 19–249, 2019). Patient data were anonymized.
: Not applicable as all data are anonymized.
: Not applicable as all data are anonymized.